Reporting of 6-month vs 12-month data in a clinical trial of celecoxib

JAMA. 2001 Nov 21;286(19):2398; author reply 2399-400.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Celecoxib
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects*
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Membrane Proteins
  • Peptic Ulcer / chemically induced
  • Prostaglandin-Endoperoxide Synthases
  • Pyrazoles
  • Sulfonamides / adverse effects*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Pyrazoles
  • Sulfonamides
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Celecoxib